New drugs for alopecia areata have begun to gain FDA approval, including one in 2023. The Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of Medicine is on a mission to create even more options through Mount Sinai’s Alopecia Center of Excellence.